ArticleCase reports in oncology

Dual HER2 Suppression with Lapatinib plus Trastuzumab for Metastatic Inflammatory Breast Cancer: A Case Report of Prolonged Stable Disease.

Lauren Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.